Universität Zürich
»
Forschungsdatenbank
»
Projektübersicht
Home
|
Kontakt
|
Sitemap
Forschungsdatenbank
Projektübersicht
•
Login
•
Suche
Dr. Alexander Navarini - Dermatologische Immunologie
Fakultäten
»
Medizinische Fakultät
»
Dermatologische Klinik
»
Dr. Alexander Navarini
Current research projects
Project leader
Project title
French
A PHASE II MULTI CENTER OPEN LABEL PILOT STUDY TO ASSESS A POTENTIAL EFFECT OF AN ANTI-IL-1-β ANTAGONIST IN THE TREATMENT OF PYODERMA GANGRENOSUM
Hofbauer
IMPACT OF UVA ON PRURITUS DURING UVA/B-PHOTOTHERAPY OF INFLAMMATORY DERMATOSES – A RANDOMIZED DOUBLE-BLIND STUDY
Navarini
Cost of biologics vs inpatient treatment for moderate-to-severe psoriasis in Switzerland
Role of opposing cytokine signals in psoriasis
Completed research projects
Project leader
Project title
Conrad
Combined Inhibition of Dipeptidyl Peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/CD13) in the Treatment of Psoriasis
Navarini
Long-lasting immunity by early infection of maternal-antibody-protected infants.
Prevalence of dermatoses and quality of life impairment in internal medicine patients
Dermoscopic criteria of nummular eczema
The role of antimicrobial peptides and interferon in rosacea
Prevalence and subjective impairment of quality of life (QoL) due to dermatologic diseases in internal medicine patients
The role of plasmacytoid dendritic cells and type 1 interferon production in rosacea
Evidence-based skin rejuvenation
Radiotherapy of extramammary M.Paget, a retrospective long-term analysis
Navarini Conrad
Role of T cell subsets in development of psoriasis
Navarini Trüeb
3 Cases of Dissecting Cellulitis of the Scalp Treated with Adalimumab: Control of Inflammation within Residual Structural Pathology
Navarini Zinkernagel
Innate immune-induced depletion of bone marrow neutrophils aggravates systemic bacterial infections
Recher
Non-specific B cell activation and autoantibodies in chronic virus infection
Trüeb
Estimation of cost-of-illness in patients with psoriasis in Switzerland.
Zinkernagel
Increased susceptibility to bacterial superinfection as a consequence of innate antiviral responses